We are live on ! Find out more
AV

ASR Vermogensbeheer Portfolio holdings

AUM $8.5B
1-Year Est. Return 25.14%
This Fund
S&P 500
This Quarter Est. Return
-3.12%
1 Year Est. Return
+25.14%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$8.5B
AUM Growth
-$96.1M
Cap. Flow
+$411M
Cap. Flow %
4.83%
Top 10 Hldgs %
34.38%
Holding
534
New
8
Increased
456
Reduced
39
Closed
2

Top Buys

1
AZN icon
AstraZeneca
AZN
+$162M
2
SUNB
Sunbelt Rentals Holdings
SUNB
+$41.2M
3
NVDA icon
NVIDIA
NVDA
+$33.2M
4
UBS icon
UBS Group
UBS
+$19.4M
5
AAPL icon
Apple
AAPL
+$16.9M

Top Sells

1
META icon
Meta Platforms (Facebook)
META
+$17.1M
2
BDX icon
Becton Dickinson
BDX
+$8.94M
3
SLB icon
SLB Ltd
SLB
+$7.67M
4
GIB icon
CGI
GIB
+$4.75M
5
AMAT icon
Applied Materials
AMAT
+$3.24M

Sector Composition

1 Technology 30.92%
2 Financials 13.2%
3 Healthcare 11.8%
4 Consumer Discretionary 10.12%
5 Communication Services 10.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TMUS icon
51
T-Mobile US
TMUS
$208B
$34.4M 0.4%
163,828
+4,067
+3% +$835K
NOW icon
52
ServiceNow
NOW
$106B
$34.1M 0.4%
326,242
+18,472
+6% +$2.17M
CSCO icon
53
Cisco
CSCO
$441B
$33.9M 0.4%
436,587
+7,595
+2% +$595K
HD icon
54
Home Depot
HD
$338B
$33.7M 0.4%
102,465
+1,773
+2% +$646K
MRK icon
55
Merck
MRK
$315B
$33.6M 0.39%
278,937
+5,059
+2% +$584K
AME icon
56
Ametek
AME
$54.3B
$33.5M 0.39%
156,281
-143
-0.1% -$31.8K
XYL icon
57
Xylem
XYL
$29.2B
$33.2M 0.39%
277,547
+3,758
+1% +$493K
ILMN icon
58
Illumina
ILMN
$28.2B
$33.2M 0.39%
269,032
+523
+0.2% +$68.7K
NKE icon
59
Nike
NKE
$64.9B
$33M 0.39%
624,701
+21,864
+4% +$1.33M
IEX icon
60
IDEX
IEX
$16.6B
$32.5M 0.38%
171,719
+247
+0.1% +$48.8K
GS icon
61
Goldman Sachs
GS
$314B
$31.2M 0.37%
36,929
+602
+2% +$537K
BSX icon
62
Boston Scientific
BSX
$65.4B
$30.4M 0.36%
483,854
+6,526
+1% +$522K
FAST icon
63
Fastenal
FAST
$52.2B
$30.1M 0.35%
649,477
+18,293
+3% +$821K
ELAN icon
64
Elanco Animal Health
ELAN
$12.9B
$29.8M 0.35%
1,243,255
-84,118
-6% -$2.06M
IBM icon
65
IBM
IBM
$200B
$29.3M 0.34%
120,828
+2,150
+2% +$582K
APO icon
66
Apollo Global Management
APO
$69.5B
$29.2M 0.34%
262,143
+4,464
+2% +$553K
HEI icon
67
HEICO Corp
HEI
$47.9B
$29.1M 0.34%
106,131
+176
+0.2% +$56.7K
AYI icon
68
Acuity Brands
AYI
$9.99B
$27.4M 0.32%
97,748
– –
GEV icon
69
GE Vernova
GEV
$284B
$27M 0.32%
30,983
+515
+2% +$402K
HAL icon
70
Halliburton
HAL
$29.4B
$26.7M 0.31%
685,875
-42,919
-6% -$1.49M
BKR icon
71
Baker Hughes
BKR
$55.5B
$26.7M 0.31%
437,011
-7,996
-2% -$462K
LRCX icon
72
Lam Research
LRCX
$392B
$26.6M 0.31%
124,686
+2,154
+2% +$482K
ORCL icon
73
Oracle
ORCL
$364B
$26.3M 0.31%
178,447
+3,084
+2% +$501K
MCD icon
74
McDonald's
MCD
$190B
$26.2M 0.31%
84,414
+1,554
+2% +$495K
MS icon
75
Morgan Stanley
MS
$339B
$26.1M 0.31%
158,794
+2,908
+2% +$503K
1 2
3
4 5

Similar funds

GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NB
Norinchukin Bank Tokyo, Japan $8.57B AUM 20.17% 1-Year Est. Return
ACM
Advisors Capital Management Ridgewood, New Jersey $8.58B AUM 23.43% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return

ASR Vermogensbeheer's Q1 2026 Portfolio in Review

As of Q1 2026, ASR Vermogensbeheer held 534 positions worth $8.5B, down 1.1% from $8.6B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

ASR Vermogensbeheer deployed $411M of net new capital in Q1 2026, opening 8 new positions and adding to 456 existing holdings. Its largest new stake was AstraZeneca: 841,921 shares worth $163M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $17.1M trimmed.

  • ASR Vermogensbeheer's largest Q1 2026 buy was AstraZeneca: 841,921 shares worth $163M.
  • ASR Vermogensbeheer added most to NVIDIA in Q1 2026, an estimated $33.2M increase.
  • ASR Vermogensbeheer's biggest Q1 2026 reduction was Meta Platforms (Facebook), cutting an estimated $17.1M.
  • ASR Vermogensbeheer fully exited Amrize Ltd in Q1 2026, selling an estimated $1.58M.
  • ASR Vermogensbeheer's ten largest holdings make up 34% of its $8.5B portfolio in Q1 2026.
  • ASR Vermogensbeheer opened 8 new positions and closed 2 in Q1 2026.
  • ASR Vermogensbeheer's portfolio value fell 1.1% quarter-over-quarter to $8.5B.

Based on ASR Vermogensbeheer's 13F filing for Q1 2026, filed 30 Apr 2026.